Abstract
Rheumatoid arthritis (RA) is an inflammatory disorder of the joints that affects 0.5–1 % of adults. Excessive growth of the fibroblast-like synoviocytes (FLS) promotes hyperplasia of synovial tissues and causes its invasion into the bone and cartilage, which eventually causes deformity and dysfunction of affected joints. Interleukin 35 (IL-35) was shown to suppress the inflammatory responses to collagen-induced arthritis (CIA) via upregulation of T regulatory cells and suppression of T helper type 17 cells in a mouse model. To study the effects of IL-35 on the proliferation and apoptosis frequency of cultured FLS isolated from mice with CIA as well as to examine the effects of IL-35 on CIA in vivo. Thirty DBA/1 J mice, which are used as an animal model for RA, were divided randomly (ten mice per group) to a CIA group (collagen treatment), a CIA + IL-35 group (collagen and IL-35 treatments), and a control group (no treatment). Starting on the 24th day after collagen administration, IL-35 was injected intraperitoneally into mice of the CIA + IL-35 group once per day for 10 days. An arthritis index was calculated, and pathological analysis of synovial tissue was performed. FLS isolated from CIA mice were treated with various concentrations of IL-35 (12.5–100 ng/ml). The MTT assay was used to examine FLS proliferation, and apoptosis frequency of FLS was detected by flow cytometry. On day 24, the CIA mice began to exhibit arthritis symptoms, and the symptoms rapidly progressed with time. Treatment with IL-35 significantly alleviated arthritis symptoms and reduced the synovial tissue inflammation. In addition, IL-35 treatment inhibited proliferation and promoted apoptosis in cultured FLS from CIA mice in a dose-dependent manner. IL-35 could ameliorate the symptoms of arthritis in the CIA mouse model in vivo and inhibited FLS proliferation while promoting FLS apoptosis in vitro, thereby exhibited the potential in inhibiting the progression of RA.
Similar content being viewed by others
Abbreviations
- RA:
-
Rheumatoid arthritis
- FLS:
-
Fibroblast-like synoviocytes
- IL-35:
-
Interleukin-35
- Th17:
-
T helper type 17
- CIA:
-
Collagen-induced arthritis
- MTT:
-
3-(4,5-Dimethyl-thiazoyl-2-yl)-2,5-diphenyltetrazolium bromide
- MMPs:
-
Matrix metalloproteinases
- IACUC:
-
Institutional Animal Care and Use Committee
- CFA:
-
Complete Freund’s adjuvant
- IFA:
-
Incomplete Freund’s adjuvant
- FBS:
-
Fetal bovine serum
- HE:
-
Hematoxylin and eosin
- H-DMEM:
-
High glucose dulbecco’s modified eagle’s medium
- H2O2 :
-
Hydrogen peroxide
- DAB:
-
3,3-Diaminobenzidine
- SDS-PAGE:
-
Sodium dodecylsulphate-polyarcylamide gel electrophoresis
- ANOVA:
-
One-way analysis of variance
- SD:
-
Standard deviation
- LSD:
-
Least significant difference
- Ao-SMCs:
-
Human aortic smooth muscle cells
References
Scott DL, Wolfe F, Huizinga TW (2010) Rheumatoid arthritis. Lancet 376(9746):1094–1108. doi:10.1016/S0140-6736(10)60826-4
Jutley G, Raza K, Buckley CD (2015) New pathogenic insights into rheumatoid arthritis. Curr Opin Rheumatol 27(3):249–255
Bartok B, Firestein GS (2010) Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 233(1):233–255. doi:10.1111/j.0105-2896.2009.00859.x
Tolboom TC, Pieterman E, van der Laan WH, Toes RE, Huidekoper AL, Nelissen RG, Breedveld FC, Huizinga TW (2002) Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10. Ann Rheum Dis 61(11):975–980
Firestein GS, Yeo M, Zvaifler NJ (1995) Apoptosis in rheumatoid arthritis synovium. J Clin Invest 96(3):1631–1638. doi:10.1172/JCI118202
Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K, Nishioka K (1995) Apoptosis and functional fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 38(4):485–491
Li H, Wan A (2013) Apoptosis of rheumatoid arthritis fibroblast-like synoviocytes: possible roles of nitric oxide and the thioredoxin 1. Mediators Inflamm 2013:953462
Yoon CH, Chung SJ, Lee SW, Park YB, Lee SK, Park MC (2013) Gallic acid, a natural polyphenolic acid, induces apoptosis and inhibits proinflammatory gene expressions in rheumatoid arthritis fibroblast-like synoviocytes. Joint Bone Spine 80(3):274–279. doi:10.1016/j.jbspin.2012.08.010
Yi JK, Kim HJ, Yu DH, Park SJ, Shin MJ, Yuh HSB, Ji YR, Kim R, Park J, Kim Y, Lee HS (2013) Regulation of inflammatory responses and fibroblast-like synoviocyte apoptosis by calcineurin-binding protein 1 in mice. Arthritis Rheum 64(7):207
Castellani M, Anogeianaki A, Felaco P, Toniato E, De Lutiis M, Shaik B, Fulcheri M, Vecchiet J, Tete S, Salini V (2009) IL-35, an anti-inflammatory cytokine which expands CD4 + CD25 + Treg cells. J Biol Regul Homeost Agents 24(2):131–135
Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, Cross R, Sehy D, Blumberg RS, Vignali DA (2007) The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450(7169):566–569. doi:10.1038/nature06306
Neurath MF (2008) IL-12 family members in experimental colitis. Mucosal Immunol 1(Suppl 1):S28–S30. doi:10.1038/mi.2008.45
Niedbala W, Xq Wei, Cai B, Hueber AJ, Leung BP, McInnes IB, Liew FY (2007) IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 37(11):3021–3029
Senolt L, Sumova B, Jandova R, Hulejova H, Mann H, Pavelka K, Vencovsky J, Filkova M (2015) Interleukin 35 synovial fluid levels are associated with disease activity of rheumatoid arthritis. PLoS One 10(7):e0132674. doi:10.1371/journal.pone.0132674
Filkova M, Vernerova Z, Hulejova H, Prajzlerova K, Veigl D, Pavelka K, Vencovsky J, Senolt L (2015) Pro-inflammatory effects of interleukin-35 in rheumatoid arthritis. Cytokine 73(1):36–43. doi:10.1016/j.cyto.2015.01.019
Anthony DD, Haqqi TM (1999) Collagen-induced arthritis in mice: an animal model to study the pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol 17(2):240–244
Sun Y, Cheung JM, Martel-Pelletier J, Pelletier JP, Wenger L, Altman RD, Howell DS, Cheung HS (2000) Wild type and mutant p53 differentially regulate the gene expression of human collagenase-3 (hMMP-13). J Biol Chem 275(15):11327–11332
Perlman H, Bradley K, Liu H, Cole S, Shamiyeh E, Smith RC, Walsh K, Fiore S, Koch AE, Firestein GS, Haines GK 3rd, Pope RM (2003) IL-6 and matrix metalloproteinase-1 are regulated by the cyclin-dependent kinase inhibitor p21 in synovial fibroblasts. J Immunol 170(2):838–845
Kuo J, Nardelli DT, Warner TF, Callister SM, Schell RF (2011) Interleukin-35 enhances lyme arthritis in Borrelia-vaccinated and -infected mice. Clin Vaccine Immunol 18(7):1125–1132. doi:10.1128/CVI.00052-11
Li X, Mai J, Virtue A, Yin Y, Gong R, Sha X, Gutchigian S, Frisch A, Hodge I, Jiang X, Wang H, Yang XF (2012) IL-35 is a novel responsive anti-inflammatory cytokine—a new system of categorizing anti-inflammatory cytokines. PLoS One 7(3):e33628. doi:10.1371/journal.pone.0033628
Collison LW, Chaturvedi V, Henderson AL, Giacomin PR, Guy C, Bankoti J, Finkelstein D, Forbes K, Workman CJ, Brown SA, Rehg JE, Jones ML, Ni HT, Artis D, Turk MJ, Vignali DA (2010) IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 11(12):1093–1101. doi:10.1038/ni.1952
Collison LW, Pillai MR, Chaturvedi V, Vignali DA (2009) Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35-and IL-10-dependent manner. J Immunol 182(10):6121–6128
Whitehead GS, Wilson RH, Nakano K, Burch LH, Nakano H, Cook DN (2012) IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J Allergy Clin Immunol 129(1):207–215. doi:10.1016/j.jaci.2011.08.009 e201-205
Wirtz S, Billmeier U, Mchedlidze T, Blumberg RS, Neurath MF (2011) Interleukin-35 mediates mucosal immune responses that protect against t-cell–dependent colitis. Gastroenterology 141(5):1875–1886
Long J, Zhang X, Wen M, Kong Q, Lv Z, An Y, Wei XQ (2013) IL-35 over-expression increases apoptosis sensitivity and suppresses cell growth in human cancer cells. Biochem Biophys Res Commun 430(1):364–369. doi:10.1016/j.bbrc.2012.11.004
Tao Q, Pan Y, Wang Y, Wang H, Xiong S, Li Q, Wang J, Tao L, Wang Z, Wu F, Zhang R, Zhai Z (2015) Regulatory T cells-derived IL-35 promotes the growth of adult acute myeloid leukemia blasts. Int J Cancer 137(10):2384–2393. doi:10.1002/ijc.29563
Nicholl MB, Ledgewood CL, Chen X, Bai Q, Qin C, Cook KM, Herrick EJ, Diaz-Arias A, Moore BJ, Fang Y (2014) IL-35 promotes pancreas cancer growth through enhancement of proliferation and inhibition of apoptosis: evidence for a role as an autocrine growth factor. Cytokine 70(2):126–133. doi:10.1016/j.cyto.2014.06.020
Skowron W, Zemanek K, Wojdan K, Gorzelak P, Borowiec M, Broncel M, Chalubinski M (2015) The effect of interleukin-35 on the integrity, ICAM-1 expression and apoptosis of human aortic smooth muscle cells. Pharmacol Rep 67(2):376–381. doi:10.1016/j.pharep.2014.10.015
Acknowledgments
This work was supported by Grants from the National Natural Science Foundation of China (Nos. 81172867, 81471542).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no financial or commercial conflict of interest.
Rights and permissions
About this article
Cite this article
Li, Y., Wu, S., Li, Y. et al. Interleukin-35 (IL-35) inhibits proliferation and promotes apoptosis of fibroblast-like synoviocytes isolated from mice with collagen-induced arthritis. Mol Biol Rep 43, 947–956 (2016). https://doi.org/10.1007/s11033-016-4034-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-016-4034-7